7GAHAM I M, DALY L E, REFSUM H M, et al. Plasma ho- mocysteine as a risk factor for vascular disease. The Europe- an Concerted Action Project [ J ]. JAMA, 1997,277 (22) :1775-1781.
8ROTHWEL P M, HOWARD S C, DOLAN E, et al. Prognos- tic significance of visit-to-visit variability maximum systolic blood pressure and episodic hypertension [ J ]. Lancet ,2010, 375 (12) :895-905.
9WEBB A J, FISCHER U, MEHTA Z, et al. Effects of antihy- pertensivedrug class on interindividual variation in bloodpressure and risk of stroke:a systematic review and meta-a- nalysis [ J ]. Lancet,2010,375 (12) :906-915.
10David S Wald,Malcolm Law,Joan K Morris.Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. British Medical Journal . 2002
